Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors 

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) announced that Casey M. Tansey will retire from its Board of Directors on July 30 after more than 18 years of service. Tansey, representing U.S. Venture Partners, led Inspire’s Series A financing in November 2007 and has served on the Board since then. The company expects to appoint a new director to replace him in the near future.

News Market Reaction – INSP

-3.98%

2 alerts

-3.98% Session close to close

$1.53B Market Cap

0.3x Rel. Volume

In the Jul 22 session, INSP declined 3.98%, reflecting a moderate negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, July 22, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced the retirement of Casey M. Tansey from the Inspire Board after more than eighteen years of service, effective July 30.

“We are thankful for the many contributions Mr. Tansey has made to our Board of Directors over the past eighteen years,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical Systems. “As one of the first venture investors to recognize the potential impact of Inspire therapy for patients with OSA, Mr. Tansey has provided valuable mentorship, leadership, and perspective throughout the Company’s founding, initial public offering and subsequent growth. We are grateful for his long-standing commitment and wish Mr. Tansey the very best in the future.”

Mr. Tansey represented U.S. Venture Partners, led Inspire’s Series A financing in November 2007 and has served on the Inspire Board of Directors since that time. The Company expects to announce the appointment of a new Director to replace Mr. Tansey in the near future.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA-, EU MDR- and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

What board change did Inspire Medical Systems (NYSE: INSP) announce on July 22, 2026?

Inspire Medical Systems announced that Casey M. Tansey will retire from its Board of Directors, effective July 30. According to Inspire Medical Systems, Tansey has served more than 18 years and represented U.S. Venture Partners throughout the company’s founding and growth.

When is Casey M. Tansey’s retirement from the Inspire Medical Systems (INSP) board effective?

Casey M. Tansey’s retirement from the Inspire Medical Systems Board of Directors is effective July 30. According to Inspire Medical Systems, he has served on the board since leading the company’s Series A financing in November 2007 as a representative of U.S. Venture Partners.

Who is Casey M. Tansey in relation to Inspire Medical Systems (INSP)?

Casey M. Tansey is a long-serving director on the Inspire Medical Systems board and a representative of U.S. Venture Partners. According to Inspire Medical Systems, he led the company’s Series A financing in November 2007 and has provided mentorship since its founding and IPO.

Will Inspire Medical Systems (INSP) replace Casey M. Tansey on its board?

Inspire Medical Systems expects to appoint a new director to replace Casey M. Tansey. According to Inspire Medical Systems, this appointment is anticipated in the near future following Tansey’s retirement from the Board of Directors effective July 30.

What role did U.S. Venture Partners play in Inspire Medical Systems (INSP)?

U.S. Venture Partners, represented by Casey M. Tansey, led Inspire Medical Systems’ Series A financing in November 2007. According to Inspire Medical Systems, Tansey’s early venture investment support and board service have spanned the company’s founding, initial public offering, and subsequent growth.

What type of company is Inspire Medical Systems (NYSE: INSP)?

Inspire Medical Systems is a medical technology company focused on minimally invasive treatments for obstructive sleep apnea. According to Inspire Medical Systems, its therapy is designed as an innovative solution for patients with OSA, supporting the company’s long-term growth and clinical adoption.